Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N, WKN: A422EZ) ("Redwood" or the "Company") is pleased to announce that it has entered into a ...

Broadcast Retirement Network's Jeffrey Snyder discusses the use of Artificial Intelligence in the creation of new drug with Early-Stage Biotech Scientist Andrew R. Snyder, PhD. Joining me now is Dr.

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...

The integration helps researchers understand disease biology and uncover biomarkers for developing new medicines.

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...

The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers ...

The U.S. Food and Drug Administration (FDA) announced a “real-time clinical trials” (RTCT) pilot program to permit agency reviewers to review ...

Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...

In a downbeat year for health care stocks, look for AI to boost these sector names in the second half of 2026.